Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Oct;25(9):1569-74.

Diffusion tensor images in children with early-treated, chronic, malignant phenylketonuric: correlation with intelligence assessment

Affiliations
Comparative Study

Diffusion tensor images in children with early-treated, chronic, malignant phenylketonuric: correlation with intelligence assessment

Steven Shinn-Forng Peng et al. AJNR Am J Neuroradiol. 2004 Oct.

Abstract

Background and purpose: Diffusion tensor (DT) images can provide information about the nature of white matter changes, including axonal loss and demyelination. We applied DT imaging to verify white matter changes in patients with malignant phenylketonuria (PKU) and to correlate the findings with clinical intelligence quotients (IQs).

Methods: We compared DT images with T2-weighted images in 12 patients with early-treated, chronic, stable malignant PKU and 12 age-matched control subjects. DT parameters included first, second, and third eigenvalues (EV1-3), apparent diffusion coefficients (ADCs), and fractional anisotropy (FA). Regions of interest were placed the frontoparietal, parieto-occipital, frontal and central white matter and in the anterior and posterior corpus callosum. Eight patients older than 3 years underwent IQ assessment including verbal, performance, and full-scale IQ tests.

Results: In the eight patients older than 3 years, no definite abnormal signal intensity changes were found on T2-weighted images. EV2, EV3, and FA of the parieto-occipital white matter were significantly different in patients and control subjects older than 3 years. EV3 and ADC of the parieto-occipital white matter were significantly and negatively correlated with verbal IQ (r = -0.79, P = .04) and performance IQ (r = -0.93, P = .03). FA of the parieto-occipital central white matter was positively correlated with verbal IQ (r = 0.75, P = .05).

Conclusion: Though treated early, patients with chronic, stable malignant PKU had abnormal DT findings in the parieto-occipital central white matter. EV2, EV3, and FA maps are potential tools for demonstrating brain changes due to malignant PKU.

PubMed Disclaimer

Figures

F<sc>ig</sc> 1.
Fig 1.
Control subject aged 27 months. Maps of the brain at the level of the lateral ventricular bodies show the right parietal-occipital central white matter with ROIs in the frontoparietal, parietal-occipital, frontal central white matter and in the anterior and posterior corpus callosum. A, EV1; B, EV2; C, EV3; D, trace ADC.; E, FA index. F, Color-coded fiber orientation. Left-right, anterior-posterior, and superior-inferior directions are associated with pure red, green, and blue, respectively. Combinations of these colors represent oblique fibers.
F<sc>ig</sc> 2.
Fig 2.
PKU patient aged 25 months. Cerebral maps at the level of lateral ventricular bodies. A, EV1. B, EV2 increases in the bilateral frontal and parietal-occipital central parenchyma, more prominently in the right parietal-occipital central areas (arrows). High-EV2 area is more extensive in bilateral parietal-occipital central areas than in areas shown in Figure 1B. C, High EV3 is prominent in parietal-occipital central areas, more on the right (arrows) than the left. D, ADCs are diffusely increased, slightly in the bilateral frontal, right frontoparietal, and bilateral parietal-occipital central parenchyma (arrows); the difference is not significant. E, FA is reduced in parietal-occipital central white matter, more on the right (arrows) than the left.

References

    1. Mallolas J, Vilaseca MA, Campisto J, et al. Clinical, biochemical, neurological and molecular study of 11 patients with new mutations in PAH gene. Rev Neurol 2000;31:907–910 - PubMed
    1. Scriver CR. Science, medicine and phenylketonuria. Acta Paediatr 1995;407(Suppl):11–18 - PubMed
    1. Lou HC, Guttler F, Lykkelung C, et al. Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents. Eur J Pediatr 1985;144:17–20 - PubMed
    1. Pratt OE. Transport inhibition in the pathology of phenylketonuria and other inherited metabolic diseases. J Inherit Metab Dis 1979;2(Suppl 5):75–81
    1. Pietz J. Neurological aspects of adult phenylketonuria. Curr Opin Neurol 1998;11:679–688 - PubMed

Publication types

MeSH terms